DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20194373

Gynaecological bacterial infections: the physical and psychosocial consequences and challenges of management in resource-limited settings

Charles O. Adiri, Uchenna I. Nwagha, Tochukwu C. Okeke, Emmanuel O. Izuka

Abstract


Gynecological bacterial infections (GBIs) are prevalent in our environment and as a result pose a number of physical, social and psychological consequences. These infections are acquired through several ways. Treating GBIs is a daunting task making its control the most important strategy to alleviating its physical and psychosocial consequences. To highlight the physical, social, and psychological consequences of gynaecological bacterial infections in our resource limited setting. To highlight the hugely unresolved challenges associated with the management of gynecological bacterial infections in our resource-limited setting. Several databases (Medline, Google Scholar, Pubmed, WHO’s Hinari and Wikipedia) and some selected websites were searched using the following keywords: gynecological infections, vaginal infections and discharges, vaginal flora, sexually transmitted infections, pelvic inflammatory disease, syndromic management and challenges, psychosocial consequences, alternative medicine. A total of 5470 relevant articles were obtained between 1947 and 2018. Out of these only 256 relevant articles on the topic were reviewed. However, 213 were dropped for having an incomplete submission. Forty-three (43) articles were fully accessed and referenced. The high prevalence of GBIs poses a lot of burden on the reproductive and socio-economic lives of our women. This should be matched by behavioral changes, prompt diagnosis and early treatment; facilitated by accessible and affordable health care through improved government funding.


Keywords


Gynecological infections, vaginal infections and discharges, Pelvic inflammatory disease, Psychosocial consequences, Sexually transmitted infections, Syndromic management of STIs and challenges, Vaginal flora

Full Text:

PDF

References


Gorbach SL, Menda KB, Thadepalli H, Keith I. Anaerobic flora of the cervix of healthy women. Am J Obstet Gynecol. 1973;117:1053-5.

Yamamoto T, Zhou X, Williams CJ, Hochwalt A, Forney U. Bacterial populations in the vaginas of healthy adolescent women. J Pediatric Adolesc Gynecol. 2009;22:11-8.

Zhou X, Bent SJ, Schneider MG, Davies CC, Islam MR, Forney U. Characteristics of vaginal microbial communities in adult healthy women using cultivation independent methods. Microbiol. 2004;150:2565-73.

Shi Y, Chen L, Tong J, Xu C. Preliminary characterization of vaginal microbiota in healthy Chinese women using cultivation independent methods. J Obstet Gynecol Res. 2009;35:525-32.

Keane FE, Ison CA, Taylor-Robinson DA. A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS. 1997;8:489.

Wertz J, Isaacs Cosgrave N, Holzman C, Marsh TL. Temporal shifts in microbial communities in Non-pregnant African-American women with and without bacterial vaginosis. Inter Persp Infect Dis. 2008;18:123-5.

Srinivasan S, Liu C, Mitchell CM, Fiedler TL, Thomas KK, Agnew KJ, et al. Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. Plos ONE. 2010;5:e10197.

Lamont R, Sobel J, Akins R, Hassan S, Chaiworapongsa T, Kusanovic J, et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG. 2011;118:533-49.

Johnson SR, Petzold CR, Galask RP. Qualitative and quantitative changes of the vaginal microbial flora during the menstrual cycle. Am J Reprod Immunol Microbiol. 1985;9:1-5.

Witkin SS, Linhares IM, Giraldo P. Bacterial flora of the female genital tract; function and immune regulation. Best Pract Res Clin Obstet Gynecol. 2007;21:347-54.

Digma F. HIV-infected women of Burkina Faso: a “reservoir” of mycoplasma infection. J Infect Dev Ctries. 2011;3(5):176-81.

Martino J, Vermund SH. Vaginal douching: evidence for risks and benefits to women’s health. Epidemiol Rev. 2002;24:109-24.

Currie MJ, Bowden FJ. The importance of chlamydial infection in obstetrics and gynecology: An update. Aus NZ J Obstet Gynaecol. 2007;47:2-8.

Lauman EO. Racial/Ethnic group differences in the prevalence of sexually transmitted diseases in the United States: a network explanation. Sex Transm Dis. 1999;26(5):250-61.

Centre for diseases control factsheet: pelvic inflammatory disease, 2011. Available at: https://www.cdc.gov/std/pid/stdfact-pid/htm. Accessed on 11th December 2015.

Einwater LA, Ritchie JM, Ault KA, Smith M. Gonorrhea and chlamydial infection among women visiting Family Planning Clinics: Racial variation, Prevalence and Predictors. Persp Sex Reprod Health. 2005;37(3):135-40.

Johnson LF, Coetzee DJ, Dorrington RE. Sentinel surveillance of sexually transmitted infections in South Africa: a review. Sex Transm Infect. 2005;81:287-93.

Hogben M, Leichliter JS. Social determinants and sexually transmitted disease disparities. Sex Transm Dis. 2008;35(12 suppl):S13-18.

Aboyeji AP, Nwabuisi P. Prevalence of sexually transmitted diseases among pregnant women in Ilorin Nigeria. J Obs Gynecol. 2003;23(6):637-9.

Chinsembu KC. Sexually transmitted infections in adolescents. The Open Infect Dis J. 2009;3:107-17.

Ebisi NT. The impact of culture on the transmission of infectious diseases in Nigeria; The case of Awka south, Anambra State. Afr J Social Sci. 2012;2(4):173-90.

UNAIDS WORLD AIDS Report, 2011. Available at: https://www.unaids.org/en/resources/documents/2011/20111121_JC2216_WorldAIDSday_report_2011. Accessed on 21st November 2011.

The European health report 2002 - WHO/Europe - World Health Organization. Available at: www.euro.who.int/_data/assets/pdf_file/0007/98296/E76907.pdf. Accessed 15th August 2002.

WHO Global Strategy for Containment of Antimicrobial Resistance. Available at: www.who,int/csr/resources/publications/drugresist/EGlobal_Strat.pdf. Accessed on 11th January 2001.

Miller WC. Prevalence of chlamydial and gonococcal infection among young adults in the US. JAMA. 2004;291(18):2229-36.

Barret S, Taylor C. A review on pelvic inflammatory disease. Int J STD AIDS. 2005;16:715-20.

Crossman SH. The challenge of pelvic Inflammatory disease. Am Fam Physician. 2006;73:859-64.

Van Der Pol B, Kraft CS, Williams JA. Use of an adaptation of a commercially available PCR assay aimed at diagnosis of Chlamydia and gonorrhea to detect Trichomonas Vaginalis in Urogenital Specimens. J Clin Microbiol. 2006;44(2):366-73.

Arya OP. Chlamydia, other non-gonococcal and non-specific infections and Reiter’s syndrome. Liverpool UK: Department of Medical Microbiology and Genitourinary Medicine, University of Liverpool; 1998.

Blandford JM, Gift TI. Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-age women. Sex Tansm Dis. 2006;33(10 suppl):S117-S121.

Frederick R, Je Covsek MD. Severe pelvic infection and infertility. Women’s diagnostic Cyber. 2000.

French JI, McGregor JA, Parker R. Readily Treatable Reproductive tract infections preterm birth among black women. Am J Obstet Gynecol. 2006;194:1717- 26.

Jonathan DC, Stewart P. Pelvic Infections in: Dewhurst’s Textbook of Obstetrics and Gynaecology 7th edition. Keith Edmonds. Blackwell Publishing 9600 Garsington Road Oxford. 2007.

Bird FM, Rosenthal S. Psychological sequelae of sexually transmitted diseases in adolescents. Obstet Gynecol Clin North Am. 1992;19:209-18.

Duncan B, Hart G, Scoular A, Bigrigg A. Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ. 2001;322:195.

Gottlieb SL, Stoner BP, Zaidi AA, Buckel C, Tran M, Leichliter JS, et al. A prospective study of the psychosocial impact of a positive Chlamydial Trachomatis Laboratory test. Sex Transm Dis. 2011;38(11):1004-11.

Peterman TA, Tian LH, Metcalf CA. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: A case for screening. Ann Intern Med. 2006;145:564-72.

Marianne SD, Donna G. The centre for disease control and prevention guidelines for the treatment of sexually transmitted diseases: implication for Women’s health care. J Midwifery Women Health. 2003.

Training module on syndromic management of sexually transmitted infections, 2007. Available at: https://www.who.int/reproductivehealth/publications/rtis/9789241593407/en/. Accessed on 2007.

Ghebremichael M. Syndromic versus laboratory diagnosis of sexually transmitted infections in resource-limited setting. Int Sch Res Notices. AIDS. 2014.

Bosu WK. Syndromic management of sexually transmitted diseases: is it rational or scientific? Trop Med Int Health. 1999;4(22):114 -9.

Lush L, Walt G, Ogden J. Transferring Policies for treating sexually transmitted infections: what’s wrong with global guidelines? Health Policy Planning. 2003;18(1):18-30.

Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines. CID. 2011:53(3):1-12.